Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 467

Results For "NAL"

5924 News Found

Serina Fischer appointed GM India at Takeda Pharmaceuticals
People | March 02, 2022

Serina Fischer appointed GM India at Takeda Pharmaceuticals

Serina has over 17 years of experience in the biopharmaceutical industry


Singapore first to top WHO’s classification of medical regulator
News | March 01, 2022

Singapore first to top WHO’s classification of medical regulator

Achieving ML 4 brings Singapore closer to becoming a WHO listed authority, a new scheme that will be operational later this year and will list the world’s regulators of reference


Boehringer Ingelheim partners with Lifebit to capture health data
Biotech | March 01, 2022

Boehringer Ingelheim partners with Lifebit to capture health data

This collaboration aims at capturing translational disease insights from large external healthcare biobanks and maximizing value of data for drug discovery and precision medicine


Medvarsity partners with Clove Dental to launch Fellowship in Endodontics
Startup | March 01, 2022

Medvarsity partners with Clove Dental to launch Fellowship in Endodontics

110 BDS graduates admitted in week one of the launch


Novavax UK Phase 3 trial demonstrates protection from Covid-19 over six-month period
Biotech | March 01, 2022

Novavax UK Phase 3 trial demonstrates protection from Covid-19 over six-month period

High level of vaccine efficacy maintained over a 6-month period of surveillance


AstraZeneca and Neurimmune enter licencing agreement to develop and commercialise NI006
Biotech | March 01, 2022

AstraZeneca and Neurimmune enter licencing agreement to develop and commercialise NI006

Under the terms of the agreement, the upfront payment from Alexion to Neurimmune is US $ 30m


Innovent Biologics and AnHeart Therapeutics receive NMPA breakthrough designation for taletrectinib
Biotech | March 01, 2022

Innovent Biologics and AnHeart Therapeutics receive NMPA breakthrough designation for taletrectinib

The NMPA Breakthrough Therapy Designation was based on results from the Phase 2 TRUST trial of ROS1 fusion-positive NSCLC patients treated with taletrectinib, a new generation of potent ROS1 inhibitors


Bruker releases CCS-Enabled TIMScore and TIMS DIA-NN 4D Proteomics Software
Biotech | March 01, 2022

Bruker releases CCS-Enabled TIMScore and TIMS DIA-NN 4D Proteomics Software

Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies 9000 protein groups from 200 ng K562 lysate in just 35 min gradient


Synapse Medicine raises US $ 28 million to scale its medication reconciliation platform
Startup | March 01, 2022

Synapse Medicine raises US $ 28 million to scale its medication reconciliation platform

The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States


South Korea's OCI acquires 11% stake in Bukwang Pharmaceutical
Biotech | March 01, 2022

South Korea's OCI acquires 11% stake in Bukwang Pharmaceutical

Company has bought 7.73 million shares for KRW 146.1 billion thus securing the largest shareholder status in Bukwang Pharmaceutical